Integrative Treatment Methods in COVID-19

COVID-19 Clinical Trial

Official title:

Examination of the Use of Integrative Treatment Methods by Individuals Undergoing COVID-19 Acording to the Health Promotion Model: a Sample Qualitative Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05089578
• Other study ID #: Amasya U-2
• Status: Completed
• Start date: July 15, 2021
• Est. completion date: October 15, 2021

Study information

• Verified date: October 2021
• Source: Amasya University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study was conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. In this study, which was designed in the qualitative and phenomenological type, the criterion sampling method was used and 12 people were included in the sample.

Description:

This study was a qualitative type of phenomenological study conducted to examine the use of integrative treatment methods by individuals undergoing Covid-19. The study was completed with 12 people. The data were collected between July and October 2021. The interviews lasted for an average of 25-30 minutes. The data collected with the semi-structured interview form were analyzed by descriptive content analysis method after the interviews were over.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 12
• Est. completion date: October 15, 2021
• Est. primary completion date: October 15, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• individuals who underwent Covid-19 and used any of the integrative treatment methods
• agreed to participate in the study constituted the sample group. Exclusion Criteria: -

Related Conditions & MeSH terms

• COVID-19
• Health Attitude
• Patient Experience

Intervention

Other:
• focus interview
The "Information Form" including descriptive characteristics of the individuals undergoing Covid-19, the semi-structured "Interview Form", and the Complementary Therapy Use Form were used as the data collection tools. The Information Form consisted of 13 questions including socio-demographic and disease-related characteristics of individuals. In-depth interview method was used to collect data. Interviews were held by organizing video calls and online meeting programs on mobile phones both due to pandemic measures and in order to enable individuals to communicate comfortably. The time period in which the individuals felt most ready for the interview was determined and the data were collected during that time. During the interview, effective communication techniques were used, active listening was carried out and individuals were guided using question forms in accordance with the aim of the study. The interviews lasted for an average of 25-30 minutes.

Locations

Country	Name	City	State
Turkey	Amasya University Sciences Faculty	Amasya

Sponsors (1)

Lead Sponsor	Collaborator
Amasya University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Using integrative treatment method	All participants included in the study had used at least one of the integrative treatment methods.	15 July- October 2021
Primary	Kind of integrative treatment methods	It was determined that vitamin C and medicinal plants were frequently used in addition to their medical treatments.	October 2021